| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 4 |
Moxifloxacin (BAY 12-8039, Avelox)  |
102 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 8 |
Sparfloxacin (AT-4140, Zagam) |
117 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
0.25 |
≤0.12 － >64 |
Clindamycin (Cleocin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
0.5 |
≤0.06 － 1 |
Ranbezolid (RBX 7644) |
162 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.12 |
8 |
≤0.12 － >64 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.123 |
0.625 |
? － ? |
Ceftobiprole (Zeftera) |
942 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 － 1 |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 － 1 |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 － 1 |
Ranbezolid (RBX 7644) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 － 1 |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
0.125 － 32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
4 |
≤0.06 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
4 |
≤0.06 － 16 |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
32 |
0.125 － 64 |
Gentamicin (Gentamycin, Garamycin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 0.25 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 0.5 |
Levofloxacin (Levaquin, Quixin) |
175 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
89 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 4 |
Gatifloxacin (Tequin) |
102 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 8 |
Levofloxacin (Levaquin, Quixin) |
117 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 － >32 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
16 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.03 － 0.5 |
Daptomycin + 50 μg/ml Ca++ |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.03 － 0.5 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.12 － 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
117 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 － 1 |
Tigecycline (GAR-936, Tigacyl) |
175 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
≤0.25 － 4 |
Levofloxacin (Levaquin, Quixin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
175 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 － 8 |
Levofloxacin (Levaquin, Quixin) |
1464 |